LFLT News Lifeline Therapeutics Adds Two Directors: "LFLT News Lifeline Therapeutics Adds Two Directors
From: NewsBot
Penny StocksDate: September 1, 2005 10:51:00 AM
DENVER--(BUSINESS WIRE)--Sept. 1, 2005--Lifeline Therapeutics, Inc. (OTCBB:
LFLT Message Board) today announced that John B. Van Heuvelen and William L. Lister have become members of its Board of Directors.
Since June 2002, Mr. Van Heuvelen has been a member of the Board of Directors of MasTec, Inc., an NYSE listed company, and he is currently the Chairman of its Audit Committee. Mr. Van Heuvelen spent a combined 13 years with Morgan Stanley and Dean Witter Reynolds in various executive positions in the mutual fund, unit investment trust, and municipal bond divisions, including serving as President of Morgan Stanley Dean Witter Trust Company from 1993 until 1999. Since 1999, Mr. Van Heuvelen has been a private equity investor based in Denver, Colorado. His investment activities have included private telecom and technology firms, in which he still remains active.
Mr. Van Heuvelen said, 'It is with great pleasure that I accept the invitation to join the board of Lifeline. Lifeline is a company that is positioned for growth and has many opportunities for increased exposure within its consumer markets as well as the investment community. I welcome the privilege to be involved in maximizing the company's potential in both areas.'
William L. Lister retired from Roche Diagnostics Corporation as the Senior Vice President and General Manager of Patient Care in December 2004, a role he had held since 1997. Roche created an award, named in his honor, that is given annually at the Diabetes Care and Point of Care Diagnostics' National Meetings. Previously"
MSEP News Controlling Shareholder Sells Portion of MSEP Series B Preferred Shares; Change in Control of MSEP: "MSEP News Controlling Shareholder Sells Portion of MSEP Series B Preferred Shares; Change in Control of MSEP
From: NewsBot
Penny StocksDate: September 1, 2005 02:39:00 PM
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sept. 1, 2005--MotorSports Emporium, Inc. (OTCBB:
MSEP Message Board) discloses a private sale of Series B Preferred Stock.
David Keaveney, President and CEO of MotorSports Emporium, Inc. stated, 'On August 26, 2004, Intercontinental Assets Corp. acquired 2,500,000 shares of Series B Preferred Stock of Ten Stix, Inc. (now MotorSports Emporium, Inc.) through the conversion of a promissory note in the principal amount of $15,000 dated June 30, 2004 and amended August 26, 2004. Per the terms of the Certificate of Designation of the Series B Preferred Stock, the Series B Preferred Stock has voting rights based on an as-converted basis of 100 for 1. On a fully converted basis, the issued and outstanding Series B Preferred Stock account for 250,000,000 common shares of MSEP. Accordingly, Intercontinental Assets Corp established voting control of MotorSports Emporium, Inc. Robert C. Brehm is the principal shareholder, a director and officer of Intercontinental Assets Corp.'
Keaveney continued, 'The Series B Preferred Shares fundamentally influence the voting rights of MSEP. To further secure a growing business model it was essential to diversify the voting control of MSEP.'
On August 9, 2005, Robert C. Brehm, on behalf of Intercontinental Asset Corp agreed to sell one half of its Series B shares, representing 1,250,000 Series B shares, to Sunnydale, LLC and CEO David Keaveney resul"
